Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

The hypothalamus is not a bystander in Alzheimer's disease

Alzheimer's disease is well known as a disease of memory. But long before memory fades, many patients have trouble sleeping, lose their daily rhythms and show changes in metabolism and stress hormones. All of these functions are regulated by the hypothalamus, a structure at the base of the brain. A new study from the Buck Institute for Research on Aging, published on Nov. 18, 2026, in Nature,…

The hypothalamus is not a bystander in Alzheimer's disease

A study published in Nature on Nov. 18, 2026, indicates that the hypothalamus plays an active role in Alzheimer's disease rather than being a bystander. According to Medical Xpress, the hypothalamus regulates metabolism, stress hormones, sleep, and daily rhythms, and its circadian and metabolic control centers exhibit specific age-related changes in gene activity and volume early in the disease.

Research published via bioRxiv involving a meta-analysis of 405 microRNAs identified 16 associated with advanced neurofibrillary tangle pathology and four associated with intermediate pathology. The study found that five specific microRNAs showed evidence of mediating associations between protein expression and tau pathology. Findings highlighted miR-132-3p and miR-146b as recurrent hubs within inferred cell-type regulatory networks.

Ajel English reports that researchers have unveiled a new blood test designed to measure the progression of Alzheimer's in the brain, an announcement made at a clinical trials conference in Boston.

Brief written by urgent.news from Medical Xpress, Ajel English, bioRxiv — 3 reports on this story. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at medicalxpress.com →

More in Health & Medicine

More from Wednesday 18 November →